A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Seagen Inc.
UNC Lineberger Comprehensive Cancer Center
University of California, San Diego
University of Washington
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Tempus AI
National Institutes of Health Clinical Center (CC)
Elevation Oncology
Highlight Therapeutics
Janssen Pharmaceutical K.K.
Adaptimmune
Hoosier Cancer Research Network
Apexigen America, Inc.
Duke University
Stanford University
Memorial Sloan Kettering Cancer Center
University of Nebraska
pharmaand GmbH
Big Ten Cancer Research Consortium
Dana-Farber Cancer Institute
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Fox Chase Cancer Center
Boston Scientific Corporation
SCRI Development Innovations, LLC
Seagen Inc.
Alliance for Clinical Trials in Oncology
Takeda
Burzynski Research Institute
Washington University School of Medicine
Translational Oncology Research International
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
University Hospital Schleswig-Holstein
Brown University
Brown University
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
SWOG Cancer Research Network
Mayo Clinic
Eli Lilly and Company